RVL Pharmaceuticals (RVLP) Environmental, Social & Governance (ESG) Data

Employees

Data from SEC filings

Employee count

ESG framework mentions

In last year of SEC filings

Sustainability Accounting Standards Board (SASB)

No mentions

Global Reporting Initiative (GRI)

No mentions

Task Force on Climate-related Financial Disclosures (TCFD)

No mentions

UN Sustainable Development Goals (SDGs)

No mentions

ESG term mentions

In last year of SEC filings

Air Circular Clean Environment Environmental Extreme Weather Life Cycle Materials Nature Offset Package Packaging Pandemic Plastic Pollutant Raw Materials Renewable Toxic Waste Water Access African American Asian Benefits Black California Consumer Privacy Act Collective Bargaining Community Culture Customer Customer Satisfaction Cybersecurity Data Privacy Data Security Death Demographic Demographics Disability Diversity Drug Pricing Employee Employee Training Engagement Ethnicity Gender General Data Protection Regulation Health and Safety Health Care Healthcare Hire Hiring Hispanic Injuries Injury Latinx LGBTQ Minority Opioid Privacy Recall Recruit Reimbursement Retention Retirement Safety Satisfaction Skill Skilled Skills Social Society Stakeholder Supplier Supply Chain Talent Training Union Volunteer Women Workforce Working Condition Anti-corruption Antitrust Assessment Assurance Attorneys General Audit Bonus Bribery Classified Commitment Conflict of Interest Corporate Governance Corporate Purpose Corruption Department of Ethics Executive Compensation Expert Fraud Goals Governance Hedging Incentive Incentivize Independence Independent Innovation Innovative Investigation Lawsuit Leadership Litigation Long-term Majority Materiality Oversee Oversight Plaintiff Pledging Purpose R&D Reputation Reputational Research and Development Responsibility Responsible Shareholder Proposals Special Meeting Strategy Sustainability Targets Tax Transparency Voting Rights

Shareholder alignment

Proxy contests and exempt solicitations in last 3 years

No recent proxy contest or exempt solicitation filings from shareholders.

Vote support at last AGM

At the Extraordinary General Meeting, the Company’s shareholders approved the proposal to change the Company’s name from Osmotica Pharmaceuticals plc to RVL Pharmaceuticals plc, based on the following votes:

For		Against		Abstain
47,809,014		1,635,376		60,268